Physician profile
Michael A Campbell
NPI 1306839881
$5,578.63
in general payments reported to CMS, 2019-2025
27 companies · $845 in 2025
The $845 reported for 2025 was more than what 88% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $902 · 2020: $297 · 2021: $320 · 2022: $670 · 2023: $2,087 · 2024: $457 · 2025: $845.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,222 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,150 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,221.67 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,150.00 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $2,139.41 | 2020-2025 | Myday Contact Lens, Clariti Contact Lens |
| Johnson & Johnson Vision Care, INC. | $487.19 | 2019-2025 | Acuvue |
| Biotissue Holdings INC. | $410.61 | 2022-2025 | |
| Alcon Vision LLC | $307.46 | 2019-2025 | Hydrus Microstent, Rocklatan |
| Sun Pharmaceutical Industries INC. | $303.42 | 2019-2024 | Cequa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $300.89 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $269.49 | 2022-2025 | Infuse, Miebo |
| Maculogix, INC. | $188.54 | 2019 | |
| Lumenis Be INC | $127.95 | 2023 | M22 |
| Regeneron Healthcare Solutions, INC. | $120.02 | 2019 | |
| Amgen INC. | $109.65 | 2024 | Tepezza |
| Genentech USA, INC. | $109.65 | 2023 | Vabysmo |
| Abbvie INC. | $103.45 | 2022-2025 | |
| Allergan, INC. | $99.54 | 2019-2022 | |
| Lkc Technologies, INC. | $96.67 | 2024 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $94.31 | 2022-2025 | Tyrvaya |
| Optos, INC. | $46.89 | 2019 | |
| Aerie Pharmaceuticals, INC. | $46.22 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $35.36 | 2019-2021 | |
| Rxsight INC | $33.90 | 2025 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Handpiece |
| Abb Con-Cise Optical Group LLC | $28.39 | 2019 | |
| Alcon Research LLC | $27.71 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $22.62 | 2024 | Xdemvy |
| Dompe US, INC. | $21.68 | 2025 | Oxervate |
| Novartis Pharmaceuticals Corporation | $20.27 | 2020 | |
| Thea Pharma INC. | $15.08 | 2024 | Iyuzeh |
| Eyevance Pharmaceuticals LLC | $12.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.